Forbright Board Authorizes $25 Million Stock Buyback Through November 2027
FRBT sits 17% above its 52-week low of $16.5.
Summary
Forbright's board authorized repurchases of up to $25 million of common stock through November 30, 2027. There is no obligation to buy, and execution is at management's discretion subject to regulatory limits.
Key Events · Financing and Capital Events · FRBT
-
Board Authorizes $25 Million Buyback
On November 12, 2026, Forbright's board approved a program to repurchase up to $25 million of common stock, $0.001 par value.
-
Program Runs Through November 2027
The authorization remains in effect through November 30, 2027 unless earlier completed; the board may extend, suspend, or discontinue it at any time.
-
Flexible Execution, No Obligation
Repurchases may be made in open market transactions, privately negotiated deals, accelerated repurchase arrangements, tender offers, or Rule 10b5-1 plans, subject to regulatory limitations — the company is not obligated to buy any shares.
-
Follows $25 Million Note Redemption
Comes after the October 22, 2026 notice that Forbright will redeem all $25 million of its 5.75% subordinated notes due 2029 at par on December 1, 2026.
Analysis · FRBT · Finance
For a bank holding company that just swung to $20.6 million of quarterly net income, a $25 million repurchase authorization is meaningful capital-return news. It puts a standing bid under the stock and signals the board views the shares as undervalued. That said, the program is discretionary — no obligation to buy a single share — and subject to regulatory limits, so actual execution is what matters. The move also follows the October 22 notice that Forbright will redeem all $25 million of its 5.75% subordinated notes due 2029 at par on December 1, showing the company is deploying capital on both the liability and equity sides.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, FRBT was trading at $19.25 on NASDAQ in the Finance sector, with a market capitalization of approximately $1B. The 52-week trading range was $16.50 to $22.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.